Atara Biotherapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • Atara Biotherapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Atara Biotherapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $16K, a 54.3% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $15K, a 25% increase from 2022.
  • Atara Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $12K, a 73.9% decline from 2021.
  • Atara Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $46K, a 207% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15K +$3K +25% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $12K -$34K -73.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $46K +$31K +207% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-08
2020 $15K +$3K +25% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-08
2019 $12K +$56K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$44K -$30K -214% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$14K -$24K -240% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $10K +$19K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$9K +$16K +64% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$25K -$195K -115% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $170K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.